nodes	percent_of_prediction	percent_of_DWPC	metapath
Alfuzosin—CYP3A4—Temozolomide—malignant glioma	0.539	1	CbGbCtD
Alfuzosin—Influenza-like symptoms—Temozolomide—malignant glioma	0.0151	0.0358	CcSEcCtD
Alfuzosin—Cholestasis—Temozolomide—malignant glioma	0.0142	0.0337	CcSEcCtD
Alfuzosin—Liver injury—Temozolomide—malignant glioma	0.0128	0.0304	CcSEcCtD
Alfuzosin—Neuropathy—Carmustine—malignant glioma	0.0104	0.0249	CcSEcCtD
Alfuzosin—Influenza like illness—Temozolomide—malignant glioma	0.0104	0.0248	CcSEcCtD
Alfuzosin—Neuropathy—Temozolomide—malignant glioma	0.0101	0.024	CcSEcCtD
Alfuzosin—Injury—Carmustine—malignant glioma	0.00879	0.0209	CcSEcCtD
Alfuzosin—Breast disorder—Temozolomide—malignant glioma	0.00705	0.0168	CcSEcCtD
Alfuzosin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.00703	0.0167	CcSEcCtD
Alfuzosin—Bronchitis—Temozolomide—malignant glioma	0.00649	0.0154	CcSEcCtD
Alfuzosin—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00627	0.0149	CcSEcCtD
Alfuzosin—Erectile dysfunction—Temozolomide—malignant glioma	0.00621	0.0148	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Carmustine—malignant glioma	0.0061	0.0145	CcSEcCtD
Alfuzosin—Infestation—Temozolomide—malignant glioma	0.00602	0.0143	CcSEcCtD
Alfuzosin—Infestation NOS—Temozolomide—malignant glioma	0.00602	0.0143	CcSEcCtD
Alfuzosin—Neuropathy peripheral—Temozolomide—malignant glioma	0.0059	0.014	CcSEcCtD
Alfuzosin—Hepatobiliary disease—Temozolomide—malignant glioma	0.00569	0.0135	CcSEcCtD
Alfuzosin—Sinusitis—Temozolomide—malignant glioma	0.00564	0.0134	CcSEcCtD
Alfuzosin—Connective tissue disorder—Carmustine—malignant glioma	0.00549	0.0131	CcSEcCtD
Alfuzosin—Pharyngitis—Temozolomide—malignant glioma	0.00536	0.0128	CcSEcCtD
Alfuzosin—Urinary tract disorder—Temozolomide—malignant glioma	0.00533	0.0127	CcSEcCtD
Alfuzosin—Connective tissue disorder—Temozolomide—malignant glioma	0.00531	0.0126	CcSEcCtD
Alfuzosin—Urethral disorder—Temozolomide—malignant glioma	0.00529	0.0126	CcSEcCtD
Alfuzosin—Eye disorder—Carmustine—malignant glioma	0.00522	0.0124	CcSEcCtD
Alfuzosin—Flushing—Carmustine—malignant glioma	0.00519	0.0123	CcSEcCtD
Alfuzosin—Eye disorder—Temozolomide—malignant glioma	0.00505	0.012	CcSEcCtD
Alfuzosin—Cardiac disorder—Temozolomide—malignant glioma	0.00501	0.0119	CcSEcCtD
Alfuzosin—Flushing—Temozolomide—malignant glioma	0.00501	0.0119	CcSEcCtD
Alfuzosin—Angiopathy—Temozolomide—malignant glioma	0.0049	0.0117	CcSEcCtD
Alfuzosin—Mental disorder—Carmustine—malignant glioma	0.0049	0.0116	CcSEcCtD
Alfuzosin—Mediastinal disorder—Temozolomide—malignant glioma	0.00487	0.0116	CcSEcCtD
Alfuzosin—Mental disorder—Temozolomide—malignant glioma	0.00473	0.0113	CcSEcCtD
Alfuzosin—Back pain—Carmustine—malignant glioma	0.00471	0.0112	CcSEcCtD
Alfuzosin—Back pain—Temozolomide—malignant glioma	0.00455	0.0108	CcSEcCtD
Alfuzosin—Ill-defined disorder—Temozolomide—malignant glioma	0.00436	0.0104	CcSEcCtD
Alfuzosin—Angioedema—Temozolomide—malignant glioma	0.0043	0.0102	CcSEcCtD
Alfuzosin—Malaise—Temozolomide—malignant glioma	0.00424	0.0101	CcSEcCtD
Alfuzosin—Vertigo—Temozolomide—malignant glioma	0.00422	0.01	CcSEcCtD
Alfuzosin—Palpitations—Temozolomide—malignant glioma	0.00415	0.00988	CcSEcCtD
Alfuzosin—Chest pain—Carmustine—malignant glioma	0.00414	0.00985	CcSEcCtD
Alfuzosin—Arthralgia—Temozolomide—malignant glioma	0.004	0.00952	CcSEcCtD
Alfuzosin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00397	0.00946	CcSEcCtD
Alfuzosin—Oedema—Carmustine—malignant glioma	0.00397	0.00945	CcSEcCtD
Alfuzosin—Discomfort—Temozolomide—malignant glioma	0.00395	0.00941	CcSEcCtD
Alfuzosin—Infection—Carmustine—malignant glioma	0.00394	0.00938	CcSEcCtD
Alfuzosin—Dry mouth—Temozolomide—malignant glioma	0.00391	0.00931	CcSEcCtD
Alfuzosin—Thrombocytopenia—Carmustine—malignant glioma	0.00389	0.00925	CcSEcCtD
Alfuzosin—Tachycardia—Carmustine—malignant glioma	0.00388	0.00922	CcSEcCtD
Alfuzosin—Oedema—Temozolomide—malignant glioma	0.00384	0.00913	CcSEcCtD
Alfuzosin—Infection—Temozolomide—malignant glioma	0.00381	0.00907	CcSEcCtD
Alfuzosin—Nervous system disorder—Temozolomide—malignant glioma	0.00376	0.00895	CcSEcCtD
Alfuzosin—Thrombocytopenia—Temozolomide—malignant glioma	0.00376	0.00894	CcSEcCtD
Alfuzosin—Skin disorder—Temozolomide—malignant glioma	0.00373	0.00887	CcSEcCtD
Alfuzosin—Hypotension—Carmustine—malignant glioma	0.00371	0.00883	CcSEcCtD
Alfuzosin—Hyperhidrosis—Temozolomide—malignant glioma	0.00371	0.00882	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00362	0.00861	CcSEcCtD
Alfuzosin—Somnolence—Carmustine—malignant glioma	0.00353	0.0084	CcSEcCtD
Alfuzosin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.0035	0.00832	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Carmustine—malignant glioma	0.00343	0.00815	CcSEcCtD
Alfuzosin—Somnolence—Temozolomide—malignant glioma	0.00341	0.00811	CcSEcCtD
Alfuzosin—Constipation—Carmustine—malignant glioma	0.0034	0.00808	CcSEcCtD
Alfuzosin—Pain—Carmustine—malignant glioma	0.0034	0.00808	CcSEcCtD
Alfuzosin—Dyspepsia—Temozolomide—malignant glioma	0.00338	0.00803	CcSEcCtD
Alfuzosin—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00331	0.00788	CcSEcCtD
Alfuzosin—Fatigue—Temozolomide—malignant glioma	0.00331	0.00787	CcSEcCtD
Alfuzosin—Constipation—Temozolomide—malignant glioma	0.00328	0.00781	CcSEcCtD
Alfuzosin—Pain—Temozolomide—malignant glioma	0.00328	0.00781	CcSEcCtD
Alfuzosin—Feeling abnormal—Carmustine—malignant glioma	0.00327	0.00778	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Carmustine—malignant glioma	0.00325	0.00772	CcSEcCtD
Alfuzosin—Feeling abnormal—Temozolomide—malignant glioma	0.00316	0.00752	CcSEcCtD
Alfuzosin—Abdominal pain—Carmustine—malignant glioma	0.00314	0.00747	CcSEcCtD
Alfuzosin—Gastrointestinal pain—Temozolomide—malignant glioma	0.00314	0.00746	CcSEcCtD
Alfuzosin—Urticaria—Temozolomide—malignant glioma	0.00305	0.00725	CcSEcCtD
Alfuzosin—Abdominal pain—Temozolomide—malignant glioma	0.00303	0.00722	CcSEcCtD
Alfuzosin—Asthenia—Carmustine—malignant glioma	0.00285	0.00678	CcSEcCtD
Alfuzosin—Asthenia—Temozolomide—malignant glioma	0.00275	0.00655	CcSEcCtD
Alfuzosin—Diarrhoea—Carmustine—malignant glioma	0.00272	0.00646	CcSEcCtD
Alfuzosin—Pruritus—Temozolomide—malignant glioma	0.00271	0.00646	CcSEcCtD
Alfuzosin—Dizziness—Carmustine—malignant glioma	0.00263	0.00625	CcSEcCtD
Alfuzosin—Diarrhoea—Temozolomide—malignant glioma	0.00263	0.00625	CcSEcCtD
Alfuzosin—Dizziness—Temozolomide—malignant glioma	0.00254	0.00604	CcSEcCtD
Alfuzosin—Vomiting—Carmustine—malignant glioma	0.00252	0.00601	CcSEcCtD
Alfuzosin—Rash—Carmustine—malignant glioma	0.0025	0.00596	CcSEcCtD
Alfuzosin—Dermatitis—Carmustine—malignant glioma	0.0025	0.00595	CcSEcCtD
Alfuzosin—Headache—Carmustine—malignant glioma	0.00249	0.00592	CcSEcCtD
Alfuzosin—Vomiting—Temozolomide—malignant glioma	0.00244	0.0058	CcSEcCtD
Alfuzosin—Rash—Temozolomide—malignant glioma	0.00242	0.00576	CcSEcCtD
Alfuzosin—Dermatitis—Temozolomide—malignant glioma	0.00242	0.00575	CcSEcCtD
Alfuzosin—Headache—Temozolomide—malignant glioma	0.0024	0.00572	CcSEcCtD
Alfuzosin—Nausea—Carmustine—malignant glioma	0.00236	0.00561	CcSEcCtD
Alfuzosin—Nausea—Temozolomide—malignant glioma	0.00228	0.00542	CcSEcCtD
Alfuzosin—ADRA1A—GPCR ligand binding—CXCL8—malignant glioma	3.23e-05	0.000785	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—MMP3—malignant glioma	3.23e-05	0.000784	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—BDKRB2—malignant glioma	3.21e-05	0.000779	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—F2—malignant glioma	3.19e-05	0.000775	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—COX8A—malignant glioma	3.13e-05	0.000761	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—JAG2—malignant glioma	3.08e-05	0.000749	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—AKT2—malignant glioma	3.08e-05	0.000748	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PIK3CG—malignant glioma	3.06e-05	0.000742	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PTPN11—malignant glioma	3e-05	0.000729	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOTCH2—malignant glioma	2.98e-05	0.000724	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PIK3CD—malignant glioma	2.96e-05	0.000718	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—H3F3A—malignant glioma	2.94e-05	0.000714	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—F2—malignant glioma	2.92e-05	0.000709	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—KNG1—malignant glioma	2.92e-05	0.000709	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CXCR3—malignant glioma	2.91e-05	0.000707	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NTRK2—malignant glioma	2.83e-05	0.000688	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—YWHAE—malignant glioma	2.83e-05	0.000688	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FLT1—malignant glioma	2.82e-05	0.000685	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—DUSP6—malignant glioma	2.81e-05	0.000682	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—AKT2—malignant glioma	2.8e-05	0.000679	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PIK3CG—malignant glioma	2.79e-05	0.000678	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NTRK1—malignant glioma	2.78e-05	0.000675	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—JAG1—malignant glioma	2.77e-05	0.000673	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOTCH3—malignant glioma	2.76e-05	0.00067	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FBXW7—malignant glioma	2.71e-05	0.000659	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PIK3CD—malignant glioma	2.69e-05	0.000652	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—ASMT—malignant glioma	2.67e-05	0.000647	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—BDKRB2—malignant glioma	2.66e-05	0.000647	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—F2—malignant glioma	2.65e-05	0.000644	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—H3F3A—malignant glioma	2.61e-05	0.000634	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—F2—malignant glioma	2.59e-05	0.00063	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CXCR3—malignant glioma	2.59e-05	0.000628	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MMP3—malignant glioma	2.59e-05	0.000628	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PIK3CB—malignant glioma	2.58e-05	0.000626	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CDKN2B—malignant glioma	2.56e-05	0.000622	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—AKT2—malignant glioma	2.55e-05	0.000621	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PIK3CG—malignant glioma	2.54e-05	0.000616	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—YWHAE—malignant glioma	2.51e-05	0.000611	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NTRK2—malignant glioma	2.51e-05	0.000611	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—BCAN—malignant glioma	2.51e-05	0.000609	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FLT1—malignant glioma	2.5e-05	0.000608	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—DUSP6—malignant glioma	2.49e-05	0.000605	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PTPN11—malignant glioma	2.49e-05	0.000605	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PTK2—malignant glioma	2.49e-05	0.000604	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PIK3CG—malignant glioma	2.48e-05	0.000602	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—CXCL8—malignant glioma	2.48e-05	0.000602	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOTCH2—malignant glioma	2.47e-05	0.000601	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—JAG1—malignant glioma	2.46e-05	0.000598	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PIK3CD—malignant glioma	2.45e-05	0.000596	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOTCH3—malignant glioma	2.45e-05	0.000595	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HES1—malignant glioma	2.44e-05	0.000594	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NCOR1—malignant glioma	2.43e-05	0.00059	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—KNG1—malignant glioma	2.42e-05	0.000588	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FBXW7—malignant glioma	2.41e-05	0.000586	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—RAF1—malignant glioma	2.4e-05	0.000582	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—IL2—malignant glioma	2.37e-05	0.000575	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—BDKRB2—malignant glioma	2.36e-05	0.000574	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—F2—malignant glioma	2.35e-05	0.000572	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PIK3CB—malignant glioma	2.34e-05	0.000569	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PDGFRA—malignant glioma	2.33e-05	0.000565	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—AKT2—malignant glioma	2.32e-05	0.000564	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NTRK1—malignant glioma	2.31e-05	0.000561	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—AKT2—malignant glioma	2.27e-05	0.000551	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—SPP1—malignant glioma	2.26e-05	0.000549	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CG—malignant glioma	2.25e-05	0.000547	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—CXCL8—malignant glioma	2.25e-05	0.000546	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PIK3CD—malignant glioma	2.23e-05	0.000541	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PTPN11—malignant glioma	2.21e-05	0.000538	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOTCH2—malignant glioma	2.2e-05	0.000534	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PIK3CD—malignant glioma	2.18e-05	0.00053	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—KNG1—malignant glioma	2.15e-05	0.000523	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—IL2—malignant glioma	2.15e-05	0.000522	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MMP3—malignant glioma	2.15e-05	0.000521	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TERT—malignant glioma	2.14e-05	0.00052	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PIK3CB—malignant glioma	2.14e-05	0.00052	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CDKN2B—malignant glioma	2.13e-05	0.000517	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PDGFB—malignant glioma	2.09e-05	0.000508	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—FGFR1—malignant glioma	2.08e-05	0.000505	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PTK2—malignant glioma	2.07e-05	0.000502	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AKT2—malignant glioma	2.06e-05	0.000501	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—CXCL8—malignant glioma	2.06e-05	0.000499	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NTRK1—malignant glioma	2.05e-05	0.000498	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—HIF1A—malignant glioma	2.05e-05	0.000498	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HES1—malignant glioma	2.03e-05	0.000493	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—IDH2—malignant glioma	2.02e-05	0.000491	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NCOR1—malignant glioma	2.02e-05	0.00049	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—RAF1—malignant glioma	1.99e-05	0.000483	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CAV1—malignant glioma	1.98e-05	0.000481	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CD—malignant glioma	1.98e-05	0.000481	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—IL2—malignant glioma	1.97e-05	0.000477	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—KDR—malignant glioma	1.96e-05	0.000476	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PIK3CB—malignant glioma	1.94e-05	0.000472	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PDGFRA—malignant glioma	1.93e-05	0.000469	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MMP3—malignant glioma	1.91e-05	0.000463	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PIK3CB—malignant glioma	1.9e-05	0.000462	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.9e-05	0.000461	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CDKN2B—malignant glioma	1.89e-05	0.000459	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—FN1—malignant glioma	1.89e-05	0.000458	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—F2—malignant glioma	1.89e-05	0.000458	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—SPP1—malignant glioma	1.88e-05	0.000456	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—CXCL8—malignant glioma	1.87e-05	0.000454	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—BAD—malignant glioma	1.86e-05	0.000453	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—NOTCH1—malignant glioma	1.85e-05	0.000448	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PTK2—malignant glioma	1.83e-05	0.000446	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—CXCL8—malignant glioma	1.83e-05	0.000444	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CD80—malignant glioma	1.81e-05	0.000439	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—APC—malignant glioma	1.8e-05	0.000438	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CG—malignant glioma	1.8e-05	0.000438	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HES1—malignant glioma	1.8e-05	0.000438	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NCOR1—malignant glioma	1.79e-05	0.000435	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—IL2—malignant glioma	1.78e-05	0.000433	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—EGF—malignant glioma	1.78e-05	0.000433	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TERT—malignant glioma	1.78e-05	0.000432	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PTPN11—malignant glioma	1.77e-05	0.000431	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—RAF1—malignant glioma	1.77e-05	0.000429	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—IL2—malignant glioma	1.75e-05	0.000424	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—IDH1—malignant glioma	1.74e-05	0.000422	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PDGFB—malignant glioma	1.74e-05	0.000422	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FGFR1—malignant glioma	1.73e-05	0.000419	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CB—malignant glioma	1.73e-05	0.000419	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PDGFRA—malignant glioma	1.72e-05	0.000417	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—HIF1A—malignant glioma	1.7e-05	0.000413	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—BRAF—malignant glioma	1.7e-05	0.000412	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SPHK1—malignant glioma	1.68e-05	0.000408	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—SPP1—malignant glioma	1.67e-05	0.000405	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—CXCL8—malignant glioma	1.66e-05	0.000403	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AKT2—malignant glioma	1.65e-05	0.000401	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.65e-05	0.0004	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CAV1—malignant glioma	1.64e-05	0.000399	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—EGFR—malignant glioma	1.64e-05	0.000399	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—KDR—malignant glioma	1.63e-05	0.000395	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CD—malignant glioma	1.59e-05	0.000385	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—IL2—malignant glioma	1.59e-05	0.000385	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TERT—malignant glioma	1.58e-05	0.000384	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—PIK3CA—malignant glioma	1.57e-05	0.000382	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—F2—malignant glioma	1.57e-05	0.00038	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FN1—malignant glioma	1.57e-05	0.00038	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—KRAS—malignant glioma	1.55e-05	0.000377	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—BAD—malignant glioma	1.55e-05	0.000376	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PDGFB—malignant glioma	1.54e-05	0.000374	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FGFR1—malignant glioma	1.53e-05	0.000372	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—NOTCH1—malignant glioma	1.53e-05	0.000372	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—FGF2—malignant glioma	1.52e-05	0.000369	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—HIF1A—malignant glioma	1.51e-05	0.000367	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CD80—malignant glioma	1.5e-05	0.000365	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CG—malignant glioma	1.5e-05	0.000364	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—APC—malignant glioma	1.5e-05	0.000364	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—EGF—malignant glioma	1.48e-05	0.00036	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PTPN11—malignant glioma	1.47e-05	0.000357	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CAV1—malignant glioma	1.46e-05	0.000355	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—KDR—malignant glioma	1.44e-05	0.000351	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—PIK3CA—malignant glioma	1.43e-05	0.000347	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MDM2—malignant glioma	1.42e-05	0.000345	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—RAF1—malignant glioma	1.42e-05	0.000344	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—BRAF—malignant glioma	1.41e-05	0.000342	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—ERBB2—malignant glioma	1.4e-05	0.00034	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—F2—malignant glioma	1.39e-05	0.000338	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FN1—malignant glioma	1.39e-05	0.000338	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CB—malignant glioma	1.38e-05	0.000336	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—BAD—malignant glioma	1.37e-05	0.000334	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AKT2—malignant glioma	1.37e-05	0.000333	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—EGFR—malignant glioma	1.36e-05	0.000331	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—NOTCH1—malignant glioma	1.36e-05	0.00033	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CD80—malignant glioma	1.33e-05	0.000324	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTT1—malignant glioma	1.33e-05	0.000323	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—APC—malignant glioma	1.33e-05	0.000323	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CG—malignant glioma	1.33e-05	0.000323	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CXCL8—malignant glioma	1.33e-05	0.000323	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CD—malignant glioma	1.32e-05	0.00032	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—EGF—malignant glioma	1.32e-05	0.000319	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PTPN11—malignant glioma	1.31e-05	0.000318	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—PIK3CA—malignant glioma	1.3e-05	0.000317	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—KRAS—malignant glioma	1.29e-05	0.000313	CbGpPWpGaD
Alfuzosin—ADRA1D—GPCR downstream signaling—AKT1—malignant glioma	1.28e-05	0.000312	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—CASP3—malignant glioma	1.27e-05	0.000309	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—IL2—malignant glioma	1.27e-05	0.000308	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—FGF2—malignant glioma	1.26e-05	0.000306	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—BRAF—malignant glioma	1.25e-05	0.000304	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS1—malignant glioma	1.25e-05	0.000303	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AKT2—malignant glioma	1.22e-05	0.000296	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—EGFR—malignant glioma	1.21e-05	0.000294	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MMP9—malignant glioma	1.2e-05	0.000292	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PTEN—malignant glioma	1.2e-05	0.00029	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—PIK3CA—malignant glioma	1.18e-05	0.000288	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MDM2—malignant glioma	1.18e-05	0.000287	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—RAF1—malignant glioma	1.18e-05	0.000286	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CD—malignant glioma	1.17e-05	0.000284	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling by GPCR—AKT1—malignant glioma	1.17e-05	0.000283	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—ERBB2—malignant glioma	1.16e-05	0.000283	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—BCHE—malignant glioma	1.16e-05	0.000282	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	1.16e-05	0.000281	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CB—malignant glioma	1.15e-05	0.000279	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.15e-05	0.000278	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	1.15e-05	0.000278	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—FGF2—malignant glioma	1.12e-05	0.000272	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CXCL8—malignant glioma	1.1e-05	0.000268	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—VEGFA—malignant glioma	1.08e-05	0.000262	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—STAT3—malignant glioma	1.07e-05	0.00026	CbGpPWpGaD
Alfuzosin—ADRA1B—GPCR downstream signaling—AKT1—malignant glioma	1.07e-05	0.000259	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—CASP3—malignant glioma	1.06e-05	0.000256	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—IL2—malignant glioma	1.05e-05	0.000256	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	1.05e-05	0.000256	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MDM2—malignant glioma	1.05e-05	0.000255	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—RAF1—malignant glioma	1.04e-05	0.000254	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	1.03e-05	0.000251	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	1.02e-05	0.000248	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MMP9—malignant glioma	9.98e-06	0.000242	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—MYC—malignant glioma	9.93e-06	0.000241	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PTEN—malignant glioma	9.92e-06	0.000241	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	9.8e-06	0.000238	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—EGFR—malignant glioma	9.71e-06	0.000236	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling by GPCR—AKT1—malignant glioma	9.68e-06	0.000235	CbGpPWpGaD
Alfuzosin—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	9.46e-06	0.00023	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—CASP3—malignant glioma	9.38e-06	0.000228	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—IL2—malignant glioma	9.36e-06	0.000227	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—GSTP1—malignant glioma	9.23e-06	0.000224	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—KRAS—malignant glioma	9.18e-06	0.000223	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CAT—malignant glioma	8.98e-06	0.000218	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—VEGFA—malignant glioma	8.96e-06	0.000218	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—STAT3—malignant glioma	8.87e-06	0.000215	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MMP9—malignant glioma	8.86e-06	0.000215	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PTEN—malignant glioma	8.81e-06	0.000214	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	8.59e-06	0.000209	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—NCOR1—malignant glioma	8.48e-06	0.000206	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—PIK3CA—malignant glioma	8.43e-06	0.000205	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—MYC—malignant glioma	8.24e-06	0.0002	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—TP53—malignant glioma	8.16e-06	0.000198	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—EGFR—malignant glioma	8.06e-06	0.000196	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	7.96e-06	0.000193	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—STAT3—malignant glioma	7.88e-06	0.000191	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—KRAS—malignant glioma	7.62e-06	0.000185	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—MYC—malignant glioma	7.32e-06	0.000178	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—EGFR—malignant glioma	7.16e-06	0.000174	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—PIK3CA—malignant glioma	7e-06	0.00017	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—CAV1—malignant glioma	6.92e-06	0.000168	CbGpPWpGaD
Alfuzosin—ADRA1D—Signaling Pathways—AKT1—malignant glioma	6.89e-06	0.000167	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—TP53—malignant glioma	6.77e-06	0.000164	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—KRAS—malignant glioma	6.76e-06	0.000164	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CG—malignant glioma	6.3e-06	0.000153	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	6.22e-06	0.000151	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PPARG—malignant glioma	6.08e-06	0.000148	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—TP53—malignant glioma	6.01e-06	0.000146	CbGpPWpGaD
Alfuzosin—ADRA1B—Signaling Pathways—AKT1—malignant glioma	5.72e-06	0.000139	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CD—malignant glioma	5.54e-06	0.000135	CbGpPWpGaD
Alfuzosin—ADRA1A—Signaling Pathways—AKT1—malignant glioma	5.08e-06	0.000123	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CB—malignant glioma	4.83e-06	0.000117	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTGS2—malignant glioma	4.78e-06	0.000116	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PTEN—malignant glioma	4.17e-06	0.000101	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.94e-06	7.15e-05	CbGpPWpGaD
Alfuzosin—CYP3A4—Metabolism—AKT1—malignant glioma	2.4e-06	5.84e-05	CbGpPWpGaD
